These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19519408)

  • 1. Aggregation detection and removal biopharmaceutical proteins.
    Gagnon P; Arakawa T
    Curr Pharm Biotechnol; 2009 Jun; 10(4):347. PubMed ID: 19519408
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of protein aggregation.
    Philo JS; Arakawa T
    Curr Pharm Biotechnol; 2009 Jun; 10(4):348-51. PubMed ID: 19519409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of protein aggregation by L-arginine.
    Lange C; Rudolph R
    Curr Pharm Biotechnol; 2009 Jun; 10(4):408-14. PubMed ID: 19519416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To be excluded or to bind, that is the question: Arginine effects on proteins.
    Nakakido M; Kudou M; Arakawa T; Tsumoto K
    Curr Pharm Biotechnol; 2009 Jun; 10(4):415-20. PubMed ID: 19519417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress-free chromatography: affinity chromatography.
    Arakawa T; Kita Y; Sato H; Ejima D
    Curr Pharm Biotechnol; 2009 Jun; 10(4):456-60. PubMed ID: 19519423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress-free chromatography: IEC and HIC.
    Arakawa T; Kita Y; Ejima D
    Curr Pharm Biotechnol; 2009 Jun; 10(4):461-3. PubMed ID: 19519424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion exchange chromatography of proteins and clearance of aggregates.
    Yigzaw Y; Hinckley P; Hewig A; Vedantham G
    Curr Pharm Biotechnol; 2009 Jun; 10(4):421-6. PubMed ID: 19519418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of high hydrostatic pressure to dissociate aggregates and refold proteins.
    Seefeldt MB; Rosendahl MS; Cleland JL; Hesterberg LK
    Curr Pharm Biotechnol; 2009 Jun; 10(4):447-55. PubMed ID: 19519422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of additives on protein aggregation.
    Hamada H; Arakawa T; Shiraki K
    Curr Pharm Biotechnol; 2009 Jun; 10(4):400-7. PubMed ID: 19519415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation and characterization of protein aggregates and particles by field flow fractionation.
    Cao S; Pollastrini J; Jiang Y
    Curr Pharm Biotechnol; 2009 Jun; 10(4):382-90. PubMed ID: 19519413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody aggregate removal by hydroxyapatite chromatography.
    Gagnon P; Beam K
    Curr Pharm Biotechnol; 2009 Jun; 10(4):440-6. PubMed ID: 19519421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG aggregate removal by charged-hydrophobic mixed mode chromatography.
    Gagnon P
    Curr Pharm Biotechnol; 2009 Jun; 10(4):434-9. PubMed ID: 19519420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of vibrational spectroscopy to the structural characterization of monoclonal antibody and its aggregate.
    Li CH; Li T
    Curr Pharm Biotechnol; 2009 Jun; 10(4):391-9. PubMed ID: 19519414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical review of methods for size characterization of non-particulate protein aggregates.
    Philo JS
    Curr Pharm Biotechnol; 2009 Jun; 10(4):359-72. PubMed ID: 19519411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advancement in application of hydrophobic interaction chromatography for aggregate removal in industrial purification process.
    Lu Y; Williamson B; Gillespie R
    Curr Pharm Biotechnol; 2009 Jun; 10(4):427-33. PubMed ID: 19519419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of analytical methods for subvisible and visible particles.
    Narhi LO; Jiang Y; Cao S; Benedek K; Shnek D
    Curr Pharm Biotechnol; 2009 Jun; 10(4):373-81. PubMed ID: 19519412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous two-phase systems: A viable platform in the manufacturing of biopharmaceuticals.
    Rosa PA; Ferreira IF; Azevedo AM; Aires-Barros MR
    J Chromatogr A; 2010 Apr; 1217(16):2296-305. PubMed ID: 19962707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.
    Houde D; Berkowitz SA; Engen JR
    J Pharm Sci; 2011 Jun; 100(6):2071-86. PubMed ID: 21491437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate PAT solutions for biopharmaceutical cultivation: current progress and limitations.
    Mercier SM; Diepenbroek B; Wijffels RH; Streefland M
    Trends Biotechnol; 2014 Jun; 32(6):329-36. PubMed ID: 24732022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTS technologies in biopharmaceutical discovery.
    Wu G; Doberstein SK
    Drug Discov Today; 2006 Aug; 11(15-16):718-24. PubMed ID: 16846799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.